Literature DB >> 21527256

Assessment of urinary γ-glutamyltransferase and alkaline phosphatase for diagnosis of diabetic nephropathy.

José A M De Carvalho1, Sílvia J Piva, Bruna S Hausen, Guilherme V Bochi, Michelle Kaefer, Adriane C Coelho, Marta M M F Duarte, Rafael N Moresco.   

Abstract

BACKGROUND: Urinary biomarkers of tubular damage can be useful for early diagnosis of diabetic nephropathy. Thus, the aim of this study was to test the diagnostic accuracy of the urinary excretion of γ-glutamyltransferase (GGT) and alkaline phosphatase (ALP) for diagnosis of diabetic nephropathy (DN).
METHODS: Fasting glucose, fructosamine, serum creatinine, glomerular filtration rate (GFR), serum uric acid, serum albumin, and urinary albumin, creatinine, GGT and ALP were assessed in 74 type 2 diabetic patients without nephropathy and 38 type 2 diabetic patients with nephropathy.
RESULTS: Urinary GGT and ALP were threefold higher in type 2 diabetic patients with nephropathy. Significant correlations were observed between urinary albumin and GGT (r=0.439, P<0.001) and urinary albumin and ALP (r=0.305, P<0.01). Areas under the curve for GGT and ALP were 0.7696 (P<0.001) and 0.7233 (P<0.001), respectively. At a cut-off value of 72U/g creatinine, GGT demonstrated a sensitivity of 96.0% and a specificity of 52.6%. At a cut-off value of 20U/g creatinine, ALP demonstrated a sensitivity and specificity of 83.8% and 36.8%, respectively.
CONCLUSIONS: Urinary GGT and ALP have potential value in the diagnosis of nephropathy in type 2 diabetic patients, but GGT has a slightly higher ability to discriminate nephropathy than ALP.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527256     DOI: 10.1016/j.cca.2011.04.015

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Evaluation of Homocysteine and Gamma-Glutamyl Transferase Concentrations As Markers of Chronic Kidney Disease: An Indian Perspective.

Authors:  Shyamkrishnan R; Gautom K Saharia; Sandip Panda; Manaswini Mangaraj
Journal:  Cureus       Date:  2022-03-08

2.  Associations between renal hyperfiltration and serum alkaline phosphatase.

Authors:  Se Won Oh; Kum Hyun Han; Sang Youb Han
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

3.  Reduced glomerular size selectivity in late streptozotocin-induced diabetes in rats: application of a distributed two-pore model.

Authors:  Loay Lubbad; Carl M Öberg; Subramanian Dhanasekaran; Abderrahim Nemmar; Fayez Hammad; Javed Y Pathan; Bengt Rippe; Omran Bakoush
Journal:  Physiol Rep       Date:  2015-05

Review 4.  Cysteine as a Multifaceted Player in Kidney, the Cysteine-Related Thiolome and Its Implications for Precision Medicine.

Authors:  Maria João Correia; António B Pimpão; Dalila G F Fernandes; Judit Morello; Catarina O Sequeira; Joaquim Calado; Alexandra M M Antunes; Manuel S Almeida; Patrícia Branco; Emília C Monteiro; João B Vicente; Jacinta Serpa; Sofia A Pereira
Journal:  Molecules       Date:  2022-02-19       Impact factor: 4.411

5.  N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models.

Authors:  Leena Liljedahl; Maiken Højgaard Pedersen; Jenny Norlin; James N McGuire; Peter James
Journal:  Clin Proteomics       Date:  2016-10-15       Impact factor: 3.988

6.  Association between serum alkaline phosphatase and renal outcome in patients with type 2 diabetes mellitus.

Authors:  Lijun Zhao; Lin Li; Honghong Ren; Yutong Zou; Rui Zhang; Shanshan Wang; Huan Xu; Jie Zhang; Fang Liu
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.